Technologies 7890A GC system equipped with a FID detector and a 7693 Autosampler or a 7683B
Injector in combination with a 7683 Series Autosampler (columns vide infra). NMR spectra were measured on a Bruker Avance III 300 MHz NMR spectrometer. Chemical shifts are reported relative to TMS (δ = 0.00 ppm); coupling constants J are given in Hz. All enzymes were overexpressed and purified as reported [1] and used as purified protein (>90% purity). 1a, rac-1c and (S)-1c were obtained from SigmaAldrich.
Analytical Methods

Synthesis of reference material (1b)
35 g (350 mmol) of α-angelica lactone (1a) were placed in a 100 mL round bottom flask, 313 µL (2.23 mmol) Et3N were added and the reaction was stirred at reflux for 40 minutes. Afterwards, the reaction was allowed to cool to room temperature. Purification was performed via column chromatography (silica gel, eluent: hexanes/EtOAc 3:2). Yield: 9.61 g (97 mmol, 28%) of 1b.
NMR 1b (in accordance with literature [2] ):
1 H NMR (300 MHz, CDCl3) δ 7.45 (dd, J = 5.7, 1.5 Hz, 1H), 6.06 (dd, J = 5.7, 1.9 Hz, 1H), 5. 
Determination of conversions
Conversions of the substrates were determined by either GC-FID or GC/MS. For GC/MS, the temperature program was: 40 °C, hold for 2 min, 10 °C/min to 180 °C, hold for 1 min. Retention times: 1a 6.6 min, 1b 
GC/MS traces
Scale-up
The scale up was performed as described in the experimental section. Upon evaporation of the solvent, GC-MS analysis of the recovered product (18.1 mg) indicated a purity of 98% for -isomer 1b.
Determination of enantiomeric excess
Optical purity of the products was determined by GC-FID measurements by comparison with authentic 
Cloning of OYE2
The synthetic gene for OYE2 was ordered (Thermo Fisher Scientific) and codon-optimized for E. coli. 
Site-directed Mutagenesis
Primers that included the desired mutations were designed using the sequence of codon-optimized (E.
coli) OYE2-gene (Table S1 ). All mutants were generated using an Agilent QuikChange II XL SiteDirected Mutagenesis Kit. The obtained plasmids were transformed into XL10-Gold Ultracompetent Cells according to the manufacturer's manual. The correct introduction on mutations was confirmed by sequencing. Table S1 : Primers used for mutation studies (triplet encoding the new amino acid in bold letters)
Transformation of plasmids
To 100 µL of cell suspension in 1.5 mL Eppendorf tubes, 10 µL of plasmid were added and incubated on ice for 30 min. The samples were then placed in a thermoshaker 42 °C for 10 s [BL21(DE3)] and 30 s (NEB5α) respectively. Afterwards, 250 µL of LB-medium were added and the cells were incubated in the thermomixer for 1 h at 37 °C and 300 rpm. 100 µL of the resulting product were plated on kanamycincontaining agar plates.
Overexpression of OYE2 and variants
Colonies obtained from the transformation step were used to prepare overnight cultures (ONCs; 10 mL LB-medium, 50 µg/mL kanamycin) of all mutants. They were placed in the shaker overnight (37 °C, 120 rpm) and used on the next day to inoculate the main cultures (330 mL LB-medium per shaking flask; 3.3 mL of the ONCs, 50 µg/mL kanamycin). The main cultures were placed in the shaker at 37 °C and 140
rpm until an OD600 of 0.6 was reached. Then, IPTG (0.2 mM) was used for induction. The cultures were again placed in the shaker overnight at 37 °C and 140 rpm. On the next day, the cells were harvested by centrifugation (4000 rpm, 20 min, 4 °C) and the supernatant was discarded. The pellet was resuspended with cold 0.9% NaCl solution and centrifuged again (4000 rpm, 20 min, 4 °C). The supernatant was discarded and the pellets were frozen until the purification was performed.
Purification of OYE2 and variants
The pellets obtained from the overexpression were all treated as follows. Lysis buffer (Tris-HCl buffer, 50 mM, pH 7.5) was added to resuspend the pellet. The cells were then ultrasonicated (40% amplitude, 1 s pulse on, 4 s pulse off, total pulse time: 5 min), centrifuged (14000 rpm, 30 min, 4 °C). The supernatant was filtered through a 0.45 µM syringe filter and transferred into a 50 mL Sarstedt tube. Purification was performed by Ni-affinity chromatography: wash buffer: Tris-HCl (50 mM, 25 mM imidazole and 300 mM NaCl), elution buffer: TrisHCl (50 mM, 250 mM imidazole, 300 mM NaCl).
Bioreduction of N-phenyl-2-methylmaleimide
N-Phenyl-2-methylmaleimide was converted and analyzed according to published protocol. [3] Variants OYE2-H192A and Y197F were tested under standard conditions and following conversion levels were obtained: OYE2-wt: >99%; OYE2-H192A: 95%; OYE2-Y197F: 85%.
